Form 4 for HCAT Health Catalyst, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001562180-24-008097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-12-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $8.97 | -11.4K | 244.4K | -4% | -$102.5K | |
| 2024-12-03 | 2024-12-02 | HCAT | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $8.94 | -7,500 | 236.9K | -3% | -$67.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-01 | F | D | 11,431 | $8.97 | 244,450 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-02 | S | D | 7,500 | $8.94 | 236,950 | D | — | — |